Sex differences in patients undergoing transcatheter aortic valve replacement in Asia.
aortic valve stenosis
heart valve prosthesis implantation
transcatheter aortic valve replacement
Journal
Open heart
ISSN: 2053-3624
Titre abrégé: Open Heart
Pays: England
ID NLM: 101631219
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
01
12
2020
revised:
12
12
2020
accepted:
14
12
2020
entrez:
9
1
2021
pubmed:
10
1
2021
medline:
23
9
2021
Statut:
ppublish
Résumé
Transcatheter aortic valve replacement (TAVR) is increasingly performed. Physically small Asians have smaller aortic root and peripheral vessel anatomy. The influence of gender of Asian patients undergoing TAVR is unknown and may affect outcomes. The aim of this study was to assess sex differences in Asian patients undergoing TAVR. Patients undergoing TAVR from eight countries were enrolled. In this retrospective analysis, we examined differences in characteristics, 30-day clinical outcomes and 1-year survival between female and male Asian patients. Eight hundred and seventy-three patients (54.4% women) were included. Women were older, smaller and had less coronary artery and lung disease but tended to have higher logistic EuroSCOREs. Smaller prostheses were used more often in women. Major vascular complications occurred more frequently in women (5.5% vs 1.8%, p<0.01); however, 30-day stroke and mortality (women vs men: 1.5% vs 1.6%, p=0.95% and 4.3% vs 3.4%, p=0.48) were similar. Functional status improvement was significant and comparable between the sexes. Conduction disturbance and permanent pacemaker requirements (11.2% vs 9.0%, p=0.52) were also similar as was 1-year survival (women vs men: 85.6% vs 88.2%, p=0.25). The only predictors of 30-day mortality were major vascular injury in women and age in men. Asian women had significantly smaller stature and anatomy with some differences in clinical profiles. Despite more frequent major vascular complications, women had similar 30-day stroke or mortality rates. Functional status improvement was significant and comparable between the sexes. Conduction disturbance and permanent pacemaker requirements were similar as was 1-year survival.
Identifiants
pubmed: 33419935
pii: openhrt-2020-001541
doi: 10.1136/openhrt-2020-001541
pmc: PMC7798412
pii:
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: PTLC, KH, YW, W-HY, MKYL, MC, WJK, KC, M-SL and HSK have served as proctors for Edwards Lifesciences. PTLC, YW, W-HY, H-LK, MKYL, WB, Dy, KC, M-SL, KWH and HSK have served as proctors for Medtronic. WJK has served as a consultant for Medtronic.
Références
EuroIntervention. 2013 Jul;9(3):367-72
pubmed: 23872650
Ann Thorac Surg. 2015 Mar;99(3):809-16
pubmed: 25633460
Eur Heart J. 2012 Oct;33(19):2403-18
pubmed: 23026477
J Am Coll Cardiol. 2012 Sep 4;60(10):882-6
pubmed: 22818068
J Am Coll Cardiol. 2012 Feb 7;59(6):566-71
pubmed: 22300690
N Engl J Med. 2017 Apr 6;376(14):1321-1331
pubmed: 28304219
Ann Thorac Surg. 2003 Jul;76(1):75-83
pubmed: 12842517
J Thorac Cardiovasc Surg. 2014 May;147(5):1529-39
pubmed: 23856202
Am J Cardiol. 2015 Nov 15;116(10):1566-73
pubmed: 26428022
J Am Coll Cardiol. 2015 Jul 21;66(3):221-228
pubmed: 26184614
N Engl J Med. 2010 Oct 21;363(17):1597-607
pubmed: 20961243
N Engl J Med. 2016 Apr 28;374(17):1609-20
pubmed: 27040324
Catheter Cardiovasc Interv. 2014 Aug 1;84(2):293-300
pubmed: 23873857
N Engl J Med. 2019 May 2;380(18):1695-1705
pubmed: 30883058
JACC Cardiovasc Interv. 2018 Apr 23;11(8):771-780
pubmed: 29673509
JACC Cardiovasc Interv. 2016 May 9;9(9):926-33
pubmed: 27151607
Am J Cardiol. 2014 Oct 15;114(8):1269-74
pubmed: 25159239
Catheter Cardiovasc Interv. 2018 Jun;91(7):1354-1362
pubmed: 29024382
J Am Coll Cardiol. 2016 Dec 27;68(25):2733-2744
pubmed: 28007135
Singapore Med J. 2009 May;50(5):534-7
pubmed: 19495528
J Invasive Cardiol. 2020 Aug;32(8):295-301
pubmed: 32198317
N Engl J Med. 2019 May 2;380(18):1706-1715
pubmed: 30883053
Am J Cardiol. 2014 Feb 1;113(3):522-8
pubmed: 24326271
EuroIntervention. 2018 May 20;14(1):35-37
pubmed: 29786544
Catheter Cardiovasc Interv. 2017 Feb 15;89(3):429-436
pubmed: 27468953
J Am Coll Cardiol. 2019 Dec 3;74(22):2758-2767
pubmed: 31562908
Int J Cardiol. 2013 Aug 20;167(4):1373-9
pubmed: 22521376
N Engl J Med. 2011 Jun 9;364(23):2187-98
pubmed: 21639811
Interact Cardiovasc Thorac Surg. 2018 Mar 1;26(3):420-424
pubmed: 29096029